Company intelligence / Profile preview

VanEck

New York, New York, USA

Ownership: Private
Employees: ~400
Development stage: Other

Overview

VanEck is a prominent global investment management firm headquartered in New York City, specializing in exchange-traded funds (ETFs), mutual funds, and institutional accounts. While not a biotechnology research or drug development company itself, VanEck is a significant entity in the life sciences sector due to its influential thematic investment products, such as the VanEck Biotech ETF (BBH) and the VanEck Pharmaceutical ETF (PPH). These funds track indices of the largest and most liquid companies involved in drug discovery, genetic analysis, and diagnostic equipment. Founded in 1955, the firm has a long history of identifying transformative economic trends and providing investors with access to specialized sectors including healthcare, gold, and emerging markets.

Industry: Investors

Partnerships

MarketVector Indexes

Beyond the preview

Go deeper on VanEck.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VanEck.

Explore the full profile